XML 30 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900

SHARE BASED PAYMENTS (Tables)

6 Months Ended

Sep. 30, 2015

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

					Weighted
					Average			Aggregate
					Exercise Price			Intrinsic Value
		Number			(CAD)			(CAD)
Balance outstanding at March 31, 2015		4,920,000		$	1.14		$	10,120,000
Exercised		(94,640	)	$	0.60			-
Granted		50,000			0.98			-
Balance outstanding at September 30, 2015		4,875,360		$	1.15		$	-
Balance exercisable at September 30, 2015		3,272,862		$	1.15		$	-

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

					Options
					outstanding
					remaining									Number of
Number of					contractual life			Exercise			Grant date fair			options
options		Expiry date			(years)			Price (CAD)			value (CAD)			exercisable
3,520,000		June 18, 2019			3.72		$	0.60		$	0.23			2,346,667
155,360		June 20, 2019			3.72		$	0.60		$	0.23			92,860
100,000		July 14, 2017			1.79		$	2.52		$	1.06			100,000
450,000		December 8, 2019			4.19		$	2.92		$	1.65			450,000
100,000		December 8, 2019			4.19		$	2.92		$	1.49			33,334
400,000		December 8, 2019			4.19		$	2.96		$	1.56			200,000
100,000		March 16, 2020			4.46		$	3.20		$	1.61			33,334
50,000		August 15, 2015			4.88		$	0.98		$	0.45			16,667
4,875,360														3,272,862

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	September 30, 2015	September 30, 2014
Stock price	$0.872	$0.55
Exercise Price	$1.105	$0.65
Expected life	4.1 years	4.1 years
Expected volatility	67.85%	115.73%
Risk – free interest rate	1.05%	1.46%
Dividend rate	0.00%	0.00%

Schedule of Non-Employee Share-based Compensation Arrangements Fair Values [Table Text Block]

	Six months ended September 30, 2015 $	Six months ended September 30, 2014 $
Fair value of non-employee options, beginning of the period	1,581,444	-
Issuance	-	121,344
Reallocation of vested non-employee options	670,111	7,419
Change in fair value of non-employee stock options during the period	(1,889,646)	594,254
Fair value of non-employee options, end of the period	361,909	723,017

Share-Based Payments Classified in the Companys Statement of Loss [Table Text Block]

	September 30, 2015 $	September 30, 2014 $
Consulting fees	(8,899)	161,931
Research and development	(257,481)	338,657
Wages and salaries	366,898	436,809
	100,518	937,397

Schedule of Stockholder's Equity Note Warrants Or Rights Activity [Table Text Block]

		Number of warrants						Weighted Average Exercise Price
		CAD			US			CAD $			US $
Balance, March 31, 2015		8,444,400			-		$	1.00			-
Granted		-			709,164		$	-			2.97
Exercised		(14,400	)		-		$	1.00			-
Balance, September 30, 2015		8,430,000			709,164		$	1.00			2.97

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Number of warrants outstanding	Exercise Price	Expiry Date
8,430,000	CAD $1.00	May 30, 2016
452,032	US $3.00	April 30, 2018
167,731	US $3.00	June 26, 2018
18,978	US $2.15	June 26, 2020
62,878	US $3.00	July 17, 2018
7,545	US $2.15	July 17, 2020

X

- Definition

Schedule of Non-Employee Share-based Compensation Arrangements Fair Values

+ References

No definition available.

+ Details

Name:	hsm_ScheduleOfNonemployeeSharebasedCompensationArrangementsFairValuesTableTextBlock
Namespace Prefix:	hsm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of Stockholder's Equity Note Warrants Or Rights Activity

+ References

No definition available.

+ Details

Name:	hsm_ScheduleOfStockholdersEquityNoteWarrantsOrRightsActivityTableTextBlock
Namespace Prefix:	hsm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Share-Based Payments Classified in the Companys Statement of Loss

+ References

No definition available.

+ Details

Name:	hsm_SharebasedPaymentsClassifiedInTheCompanysStatementOfLossTableTextBlock
Namespace Prefix:	hsm_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

+ Details

Name:	us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 28
-Article 5

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration